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Abstract Skin, which is a protective layer of the body, is
in constant contact with physical and chemical environ-
mental factors. Exposure of the skin to highly adverse
conditions often leads to oxidative stress. Moreover, it has
been observed that skin cells are also exposed to reactive
oxygen species generated during cell metabolism par-
ticularly in relation to the synthesis of melanin or the
metabolism in immune system cells. However, skin cells
have special features that protect them against oxidative
modifications including transcription factor Nrf2, which is
responsible for the transcription of the antioxidant protein
genes such as antioxidant enzymes, small molecular an-
tioxidant proteins or interleukins, and multidrug response
protein. In the present study, the mechanisms of Nrf2 ac-
tivation have been compared in the cells forming the var-
ious layers of the skin: keratinocytes, melanocytes, and
fibroblasts. The primary mechanism of control of Nrf2
activity is its binding by cytoplasmic inhibitor Keap1,
while cells have also other controlling mechanisms, such as
phosphorylation of Nrf2 and modifications of its activators
(e.g., Maf, IKKb) or inhibitors (e.g., Bach1, caveolae,
TGF-b). Moreover, there are a number of drugs (e.g., ke-
toconazole) used in the pharmacotherapy of skin diseases
based on the activation of Nrf2, but they may also induce
oxidative stress. Therefore, it is important to look for
compounds that cause a selective activation of Nrf2 par-
ticularly natural substances such as curcumin, sul-
foraphane, or extracts from the broccoli leaves without side
effects. These findings could be helpful in the searching for
new drugs for people with vitiligo or even melanoma.
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Introduction
Skin cells, being in constant contact with the surrounding
environment, are highly susceptible to the effects of dif-
ferent stimulants. UV irradiation, xenobiotics, and thermal
stress disturb cell metabolism and consequently lead to the
increase in reactive oxygen species (ROS) generation and
to redox imbalance. UV radiation, carrying a large dose of
energy, directly converts oxygen molecules in the reactive
forms and/or causes damages of the cellular macro-
molecules structures impairing their functions [106].
However, high or low temperatures disrupt the metabolic
pathways thereby causing an overproduction of ROS that
leads to the decrease in the activity of heat-labile proteins,
in particular [32]. Metabolism of skin cells is also altered
by xenobiotics affecting ROS generation and thereby an-
tioxidant abilities, signal transductions, and the rate of
transport through membranes [31]. All the factors, leading
to an increase in ROS generation and/or a reduction in the
antioxidant capacity, contribute to oxidative stress, which
exposes the skin cells to the formation and accumulation of
irreversibly damaged proteins, lipids, nucleic acids, and
carbohydrates. This leads to a visible reduction of skin
conditions, aging, and dying cells and may also induce
malignant transformation [121].
Transcription factor Nrf2
One of the ways to defend skin cells against oxidative stress
is the transcriptional regulation of cytoprotectional genes by
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Nrf2 (Nuclear erythroid 2-related factor), in which expres-
sion in all types of epidermal cells was observed at a very
high level [63]. The transcription factor Nrf2 belongs to the
‘‘cap‘n’collar’’ (CNC) protein family, which contains the
motif called leucine zipper (bZip, basic Leucine Zipper).
This family has three-dimensional structures that allow the
formation of dimers with other proteins containing bZip
domain. The family of transcription factors containing bZIP
domain is also characterized by a basic region, which binds
via hydrogen bonds to the large groove of the DNA [55].
Under physiological conditions, Nrf2 encoding genes are
under constant expression, as a result of which Nrf2
molecule is permanently biosynthesized. However, its level
in the cytoplasm is regulated by the formation of Nrf2-
Keap1-Cul3 complex [107]. Keap1 binds Nrf2 and there-
fore directly inhibits its activity, resulting in simultaneous
Nrf2 ubiquitination catalyzed by Cul3. Binding of at least
four molecules of ubiquitin to Nrf2 causes degradation of
this molecule by the proteasome 26S. However, the ox-
idative condition in the cell leads to the oxidation of cys-
teine residues in Keap1 molecule, changing the
conformation of the protein and causing dissociation of
Nrf2 from complex [47, 82]. Free Nrf2 cannot be ubiqui-
tinated and degraded. In turn, it is translocated to the nu-
cleus, where it forms a complex with a small Maf protein
and then is bound to the DNA in a characteristic sequence
50-TGACnnnGCA-30 labeled as antioxidant responsive
element (ARE) and in consequence initiates the transcrip-
tion of antioxidant genes (Fig. 1) [50]. Nrf2 cytoprotective
action concerns mainly antioxidant enzymes such as glu-
tathione S-transferase (GST), quinone reductase NAD(P)H
(NQO1), UDP-glucuronosyltransferases (UGT), epoxide
hydrolase (EPHX), c-glutamylcysteine ligase (GCL), heme
oxygenase-1 (HO-1), glutathione reductase (GR), thiore-
doxin reductase (TrxR), catalase (CAT), and superoxide
dismutase (SOD) [76, 97, 130]. Nrf2 also activates the
transcription of non-enzymatic antioxidant protein genes
containing in their structure the ARE sequence (e.g.,
thioredoxin, ferritin) [34, 94]. The role of Nrf2 in protecting
skin cells against ROS action highlights the fact that 7 % of
squamous cell skin cancer in human results from mutations
in Nrf2 gene [49]. Additionally, Nrf2 acts as a stimulant of
anti-apoptotic proteins from Bcl-2 family [84]. The control
of a wide range of antioxidants and antiapoptotic molecules
causes that Nrf2 is recognized as a significant factor in the
cellular response to oxidative stress, especially in the cells,
which form the outer layers of the skin.
In spite of antioxidative character of Nrf2, its action may
be directly modified by ROS as well as by reactive prod-
ucts of lipid peroxidation that influence this and coop-
erative proteins, particularly during oxidative stress. It was
observed that low level of ROS causes the Nrf2 expression,
while its high level has no effect on the Nrf2 level and
leads to the irreversible cell injury and induction of apop-
tosis. However, it is also known that an intermediate level
of ROS may participate in the control of the balance be-
tween survival and apoptosis through the activation of
another transcription factor—NFjB [68, 86, 113]. There-
fore, the cooperation between members of NFjB and Nrf2
pathways may exist, and the cross-talk between Nrf2 and
NFjB under pathological conditions is suggested [9]. It has
been shown that the Keap1/Cul3 complex could regulate
both the Nrf2 and the NFjB expression through the ubiq-
uitination. Moreover, Keap1 acts as an inducible factor for
ubiquitination IKKb, which is a cytoplasmic NFjB in-
hibitor. Deletion of Keap1 leads to accumulation and sta-
bilization of IKKb and upregulation of NFjB-derived
tumor angiogenic factors [58]. On the other hand, NFjB
subunits induce transcription of Nrf2 in cells at a specific
promoter jB site and thus encourage resistance to che-
motherapy-induced cytotoxicity [24, 101]. It was also re-
ported that NFjB competes with Nrf2 as co-activator
CREB-binding protein (CBP) [66]. Moreover, NFjB re-
cruits histone deacetylase 3 (HDAC3) causing local hy-
poacetylation to hamper Nrf2 signaling [66]. However,
absence of Nrf2 induces more aggressive inflammation
through activation of NFjB and downstream proinflam-
matory cytokines [89]. Furthermore, Keap1 interacts with
the NFjB-p65 subunit, thus NFjB pathway represses the
Nrf2 transcriptional activity [126]. On the other hand, both
NFjB and Nrf2 regulate the same group of genes, in-
cluding HO-1, GCLC, Gai2, and IL-8 [23].
Moreover, it is known that products of lipid oxidative
modification generated during free radicals peroxidation as
well as during enzymatic oxidation are involved in Nrf2
action. It was shown that 4-hydroxynonenal (4-HNE), one
of the most reactive lipid peroxidation products, at nontoxic
levels can activate stress response pathways such as Nrf2/
ARE by changing Keap1 conformation [38, 109]. What is
more, cell stimulation with 4-HNE at sublethal level in-
duces adaptive response and enhances cell tolerance, pri-
marily through induction of thioredoxin via transcriptional
activation of the Nrf2 signaling pathway, thereby protecting
cells against the forthcoming oxidative stress [12]. How-
ever, ROS leads to increased expression of cyclooxyge-
nases (COX) that oxidizes arachidonic acid to PGH2 that is
further metabolized by specific PG isomerases to PGE2,
PGD2, PGF2a, TXA2, and prostacyclin I2 [118]. Dehy-
dration of PGD2 leads to generation of a reactive 15d-PGJ2
that exhibits a unique spectrum of biological effects, in-
cluding inhibition of IjB-kinase-b [99] and induction of
glutathione S-transferase gene expression and apoptosis
[53]. Moreover, 15d-PGJ2 may form adducts with Keap1
simultaneously causing dissociation of Nrf2 from complex
[25]. This mechanism of Nrf2 activation was investigated in
both keratinocytes and melanocytes [44, 56].
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Epidermis
The skin consists of three layers: epidermis, dermis, and
hypodermis. The epidermis is the outermost layer of the skin
having hydrophobic properties. It is formed mainly from
keratinocytes, but it also consists dye cells—melanocytes,
Langerhans cells—the cells responsible for immune reac-
tions, and Merkel cells—cells of the nervous system.
Nrf2 in keratinocytes
The first line of human body contact with the environment
creates keratinocytes. In order to ensure skin’s resistance to
external factors, the deep layers of the epidermis must have
a high rate of normal cells proliferation, without distur-
bance in the structure and functioning. It is believed that
the high resistance of the skin to external factors and its
quick response to damages are related to the presence of
specific receptors for growth factor (KGF—Keratinocyte
Growth Factor) on the surface of keratinocytes, produced
by mesenchymal cells. KGF is a small protein that can bind
to the specific receptors on the keratinocytes cell mem-
brane, which is a simultaneous signal to proliferation and
to create a new layer of the epidermis at the injured place.
The precise mechanism of KGF action is not completely
described yet, but a direct effect of KGF on the increase of
the Nrf2 activity was proposed [8]. However, Nrf2-de-
pendent gene expression can affect the survival, differen-
tiation, and premature death of these cells [60]. It ensures
dividing the cells resistant to mutations caused by in-
creased levels of ROS. Moreover, the increase in Nrf2
activity during keratinocytes differentiation was observed
and was confirmed by the fact that in the surficial layers of
the epidermis, which are the most vulnerable to external
factors and are faster keratinized than younger cells, there
is a higher level of antioxidant enzymes whose expression
is dependent on the Nrf2 activity [60, 92].
As in other cells, in keratinocytes, ROS are generated
during aerobic metabolism as well as through metabolism
(mainly ‘‘respiratory burst’’) of the immune system cells,
which are common in the epidermis [122]. ROS, which are
generated in order to protect the skin against pathogens,
expose keratinocytes to depletion of antioxidant abilities
and oxidative modifications of cellular components, in-
cluding transcription factor Nrf2. Interactions between
keratinocytes and immune system cells affect not only
ROS generation, but also the efficient action of immune
Fig. 1 Nrf2 activation pathways in the different skin cells: keratinocyte, melanocyte, and fibroblast. P phosphorylation and R receptor
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system [30]. Keratinocytes, as well as fibroblasts, belong to
the group of cells that can produce interleukins. Inter-
leukin-8 (IL-8) is one of the proteins whose expression is
ARE dependent, and thus its level depends on the Nrf2
activity [98]. Through the release of interleukin-8 to the
intercellular space, keratinocytes and fibroblasts provide
communications in the whole body and fast response of the
immune system to contact the harmful chemicals [127].
Increased IL-8 generation by keratinocytes is also observed
in the case of mechanical skin damage. It is probably
linked with the Nrf2 activation induced by oxidative stress
in keratinocytes adjacent to the wound [14]. Nrf2 is also
responsible for the release of others inflammatory me-
diators (e.g., IL-6, IL-1b, and GM-CSF) in the case of
allergic contact of dermatitis. Studies of the keratinocytes
line HaCaT response to allergens show that through acti-
vation of MAP kinase, Nrf2 is translocated to the nucleus.
Consequently, an increase in interleukin release is ob-
served, but the mechanism of this reaction has not yet been
completely examined [74].
As ROS can interfere with the aging process and dif-
ferentiation of keratinocytes, the maintenance of high levels
of antioxidant enzymes (mainly HO-1, NQO1, and GST) is
important for these cells. Therefore, the high activity of
Nrf2 results from the activation of Nrf2, by dissociation of
Nrf2-Keap1 complex, prevents deformation during ker-
atinocyte differentiation and even malignant transformation
[5, 92]. In the case of changing in level of another Nrf2
inhibitor—Bach1, which competes with Nrf2 for binding to
the DNA, prevention of malignant transformation was not
observed [70]. It has been shown that in Keap1-knockout
mice keratinocytes, the control of transcriptional activity
can be taken care of by a small protein Maf. In the case
when there is no Nrf2 inhibitor, Keap1 in the cytoplasm,
active, and uncontrolled Nrf2 is translocated to the nucleus,
where, only after Maf-Nrf2 complex formation, it can bind
DNA and initiate transcription of the genes. Therefore, in
the Keap1-knockout mice keratinocytes, response to stress
factors and the rate of skin aging depend on the level of Maf
protein in the nucleus [79].
Disturbances in the Nrf2 activity may lead to develop-
ment of various diseases. Allergic contact dermatitis
(ACD) is induced usually by low molecular weight of
electrophilic chemicals and metal ions, and Nrf2 is one of
the key molecules that transmits a signal of disturbed redox
balance and causes a biological response in dendritic cells,
as well as in keratinocytes, which are in contact with them.
It was shown that Nrf2 is activated by chemical sensitizers
in contact dermatitis and also plays a significant role in the
inflammatory immune responses [1, 48], which suggests
that Nrf2 could be implicated in the chemical sensitization
processes [18]. Therefore, important role of Nrf2 in con-
trolling ACD in response to sensitizers is suggested [19].
Moreover, it is demonstrated that Nrf2 activation in ker-
atinocytes is one of the objectives of coal tar application in
case of atopic dermatitis (AD) [115]. Topical application of
coal tar is one of the oldest therapies for AD. It was also
found that coal tar activates the aryl hydrocarbon receptor
(AhR), which can bind to the Nrf2 gene locus and increase
its expression [116]. As a result, higher Nrf2 level leads to
induction of NQO1 transcription [40, 116].
Extracellular Nrf2 activators in keratinocytes
Oxidative stress in keratinocytes may be generated by
xenobiotics, e.g., arsenic, which is an inducer of carcino-
genesis in HaCaT cell line. Increased ROS generation
(mainly hydrogen peroxide) lead to the increase in Nrf2
expression, at transcription and translation level, as well as
the accumulation of active Nrf2 in the nucleus of those
cells [91]. Xenobiotics strongly sensitizing skin such as
formaldehyde, eugenol, or dinitrochlorobenzene elicit the
skin’s defences through Nrf2 activation. As a result of
covalent links between these compounds and the cysteine
residues in Keap1, Nrf2 dissociates from Nrf2-Keap1-Cul3
complex and consequently begins the ARE-dependent gene
expression [10, 78]. Many chemopreventive phyto-
chemicals are known to activate Nrf2 either by oxidative or
covalent modification of its cytosolic repressor—Keap1 or
by phosphorylation of Nrf2 [15].
Nrf2 also protects skin cells from UV radiation. Over-
expression of the Nrf2 gene in mice skin keratinocytes
exposed to UVB radiation causes higher resistance to
apoptosis [54]. Incubation of the keratinocytes line HaCaT
with flavonoids, such as quercetin or kaempferol, sig-
nificantly protects cells against UV radiation with the in-
crease of Nrf2 level in the cytoplasm and cells viability
[45, 51]. Therefore, there is a constant search for a highly
selective activator of Nrf2 in keratinocytes that not induce
side effects. A promising compound of natural origin is
sulforaphane (SFN) isolated mainly from cruciferous plants
such as broccoli or brussels sprouts [103]. Mechanism of
SFN action involves a reduction in the GSH level, which in
turn alters the Keap1 conformation and its inhibitory
properties, and consequently the active Nrf2 is released
into the cytoplasm [80, 120] and enhances the expression
of antioxidant enzymes (NQO1, HO-1, cGCS) in ker-
atinocyte line HaCaT [121]. The extract containing the
SFN reduces the risk of carcinogenesis induced by UV
radiation in mice line SKH-1 [16]. Moreover, the above-
mentioned extract given to animals with benign tumor of
the skin reduced the tumor weight [104]. However, studies
conducted on volunteers subjected to UV light and treated
with SFN showed a decrease in the development of skin
erythema up to 90 % [111].
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Nrf2 activity may also be indirectly affected by the plant
sterols (e.g., (Z)-guglesterone). Their action is associated
with the activation of IjB, whereby its physiological ac-
tivator IKKb may remain in an inactive form and bind to
Keap1, thereby blocking Nrf2 ubiquitination and increas-
ing the level of active Nrf2 in cells [2]. Other compounds
that could activate Nrf2 are carbonitriles whose metabo-
lism increased NO level and can lead to nitrosylation of
Keap1 cysteine’s. This modification alters the conforma-
tion of Keap1 and leads to a release of Nrf2 into the cy-
toplasm [65]. Another natural compound that enhances
Nrf2 mRNA level and phosphorylation by ERK kinases
that leads to increase in the transcriptional Nrf2 activity is
D3T (3H-1,2-dithiole-3-thione) [57, 72]. It is also sug-
gested that dietary supplements containing ellagic acid are
based on the activation of Nrf2. It was shown that ellagic
acid results in a higher cells survival after UVA radiation.
Furthermore, these cells exhibited a higher resistance to
ROS generation and cellular components oxidative
modifications, which may be associated with increased
expression of antioxidant enzymes (HO-1 and SOD) [36].
The mechanism of certain drugs action on epidermal
keratinocytes (NHEK) is also associated with Nrf2 acti-
vation [116]. Ketoconazole, an antifungal agent from the
group of azoles, activates the cytoplasmic receptor AhR
and forms with them active transcription complex, which is
translocated to the nucleus where it binds DNA and initi-
ates gene expression [11, 69]. It is directly related to the
increase in the transcriptional Nrf2 activity, and therefore a
reduction of the inflammatory response but the exact
mechanism of the intersection of these two pathways is not
fully understood yet [52].
Nrf2 in melanocytes
Except the keratinocytes, the epidermal layer includes also
melanocytes. They are distributed mainly near the basal
membrane of the epidermis. Melanocytes are small cells
with a low content in the central and have numerous long
cytoplasmic appendixes, which penetrates the layers of
keratinocytes. There are two types of beans stored inside
these appendixes: melanosomes—capable to synthesizing
melanin and melanin grains. Melanin is responsible for the
dark pigmentation of human skin, thereby protecting the
deeper layers of the skin from UV radiation that is also a
stimulator of the melanin synthesis [85]. During melano-
genesis, tyrosinase, the major tyrosine metabolism enzyme,
may show diphenolaze (H2O2 generation) or catalase
(H2O2 decomposition) activity. Therefore, the synthesis of
melanin may be associated with higher ROS generation
[112]. Nrf2 activity protects melanocytes against the
harmful ROS effects. It has been shown that
overexpression of Nrf2 caused by transfection of plasmids
containing the Nrf2 gene (pCMV6-XL5) or Keap1 mRNA
silencing using siRNA prevents oxidative stress induced by
xenobiotics in melanocytes cell line PIG1 or NHK [41, 73].
Furthermore, ex vivo studies have shown that enhanced
level/activity of Nrf2 and protein whose synthesis is de-
pendent on this factor reduces the effects of oxidative stress
formed after exposure to UVB radiation. Nrf2 activation
mechanism in melanocytes is associated with a higher level
of melanotropine (a-MSH)—the hormone produced in the
pituitary gland, whose binding to a specific receptor on the
surface of melanocytes (MC-1R), leads to the formation of
complexes initiating ARE-dependent genes transcription
[54]. Other studies show that the increased level of active
Nrf2 is directly related to the IRES sequence (internal ri-
bosome entry sequence) contained in the Nrf2 transcript,
which is responsible for transcription-dependent redox
state [95]. This transcript receives a signal from the cyto-
plasm about the unbalanced redox status and begins syn-
thesis of the new Nrf2 molecules [104].
There is a strong evidence suggesting influence of the
degree of phosphorylation on the Nrf2 activity. As a result
of oxidative stress, Nrf2 is dissociated from Keap1-Nrf2
complex and then as a free molecule can be phosphory-
lated. On the other hand, it is known that expression of
many kinases (mainly MAPK family, PI3K) is increased
during oxidative stress; therefore, the level of phosphory-
lated Nrf2 is also rapidly increased [108]. Moreover, Nrf2
is phosphorylated by kinase ERK1/2 activated on Ras/Raf/
MEK/ERK signaling pathway [59]. On the other hand,
ERK activation in nucleus can lead to phosphorylation of
Bach1—protein, which under physiological conditions
binds DNA in a sequence of ARE, blocking the Nrf2 ac-
tivity. Phosphorylated Bach1 loses the ability to bind to
DNA and allows Nrf2 to start the transcription and an-
tioxidant protein synthesis, whereby cells become highly
resistant to the oxidative stress induced by UV radiation
[129]. Additionally, the level of phosphorylated Nrf2 is
increased by phenolic compounds that activate the PERK
kinase [114].
The number of melanocytes in the skin of people of
different races is similar, and the differences in color are
only due to the intensity of the melanin production. It is
estimated that the epidermal ratio of melanocytes to ker-
atinocytes is around 1–40 (depending on the part of the
body). After exposure to UV radiation, the amount and the
activity of the melanocytes are regulated by keratinocytes
through the synthesis and release of signaling compounds
(e.g., FGF, SCF, HGF) into the intercellular space [35].
These molecules are paracrine growth factors, and after
binding one of them to specific receptors (FGFR1/2, c-kit,
c-Met), the activation of signaling cascade pathway is re-
sponsible for cell proliferation, differentiation, and
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motility, as well as the initiation of intensity of melanin
synthesis [17].
Melanocytes, during the whole period of life, retain the
ability to proliferate, as a result of adaptation to changing
environmental conditions associated with the intensity of
solar radiation throughout the year [27]. Furthermore, the
melanocytes are highly sensitive to apoptosis caused by
chemical signals caused by bacterial toxins, microtubule
structure damaging substances, or protein synthesis in-
hibitors [37]; therefore, their reduction must be comple-
mented by continuously proliferating cells. However,
generated during proliferation and continuously accumu-
lated errors in the genome lead to uncontrolled prolif-
eration of cells and start the process of carcinogenesis,
which leads to the development of malignant melanoma
[39]. In addition, the constant oxidative stress associated
with exposure to radiation, changes in temperature, and the
effect of xenobiotics cause the accumulation of oxidative
damages in these cells. Therefore, high level of Nrf2 syn-
thesis is constantly maintained in melanocytes [41]. Studies
show that disturbances in the synthesis or activation of
Nrf2 reduce the resistance of cells to stress, both physical
and chemical, leading to cell death or to carcinogenesis
[42]. Regardless of the influence of above factors, Nrf2
activity is also dependent on the Maf—nuclear protein
level and chemical structure that may be affected by viral
infections of the skin. This causes an increase in the in-
tensity of Nrf2-Maf transcription complex formation and
their strength of DNA binding, which can lead to uncon-
trolled antiapoptotic protein overexpression and conse-
quently even to the process of carcinogenesis [62].
Extracellular Nrf2 activators in melanocytes
Nrf2 is also involved in response of the skin to many
diseases, e.g., in the case of Hailey–Hailey disease (bullous
disease, HHD); subcutaneous injection of afamelanotide
causes the increase of active Nrf2 level in melanocytes and
keratinocytes that result in a reduction in the level of ROS
and local inflammation [7]. Activation of Nrf2 may also be
associated with genetic anomalies. It has been shown that
the incidence of vitiligo in humans depends on an Nrf2
gene set. In people with vitiligo, significantly lower levels
of Nrf2 m-RNA compared to healthy subjects were re-
ported [3]. Depending on the activity of newly generated
Nrf2, resistance of melanocytes to oxidative stress and the
risk of vitiligo are changed [26, 42]. Furthermore, in me-
lanocytes from patients treated with curcumin, a strong
increase in phase II enzymes synthesis is observed, but
simultaneously it results in increase in the apoptosis in the
keratinocytes [81].
Dermis
Dermis mainly consists of fibroblasts, which are located
between the connective tissue (collagen and elastin fibers),
nerves, and blood vessels. These cells are responsible for
the synthesis and secretion of collagen, elastin, hyaluronic
acid, or glycosaminoglycans into the intercellular space,
thus providing strength and elasticity of the skin. Being in
the middle layer of the skin, fibroblasts are not directly (as
keratinocytes) exposed to the environmental factors. These
cells during the whole life have a possibility to proliferate,
especially in case of damage of the dermis, but unfortu-
nately with age their activity slows down. This is accom-
panied by a reduction in metabolic capacity and decrease in
the rate of replication, which causes the weakening and the
disappearance of the skin-supporting elements. According
to the free radical theory of aging, these changes are at-
tributed to ROS action.
Nrf2 in fibroblasts
Under physiological conditions, Nrf2 controls the proper
functioning of the fibroblasts. Studies on mouse embryonic
fibroblasts (MEFs) show that knockdown of Nrf2 genes
expression leads to a reduction in glutathione levels up to
80 % relative to wild-type cells [33]. In consequence,
knockdown of Nrf2 genes expression in mice fibroblasts
significantly reduces their resistance to oxidative stress and
survival [43], and fibroblasts derived from Nrf2 knockout
mice also exhibit a much lower resistance to oxidative
stress as compared to cells derived from control animals
[130].
Because of epidermal layer, UVB radiation does not
reach the dermis, but fibroblasts still can be exposed to
UVA. Experiments on fibroblasts show that in these cells
the Nrf2 activation occurs in varying degrees after expo-
sure to different UVA wavelengths that induce a strong
immune response, simultaneously leading to the tran-
scription of many phase II antioxidant enzymes [75].
However, UVB radiation does not cause such a reaction,
thereby leading to DNA damage and apoptosis, and the link
between Keap1-Nrf2 pathway and apoptosis in fibroblasts
was shown [46]. Tests on the mouse fibroblasts line L929
showed that H2O2-induced oxidative stress leads to the
activation of Nrf2 and induction of antioxidant gene ex-
pression, as well as to increase in the level of anti-apoptotic
proteins from Bcl-2 family [46]. It was shown that fi-
broblasts with Bcl-2 gene silencing and fibroblasts incu-
bated with an inhibitor of Bcl-2 protein (HA14-1) have
reduced level of active Nrf2 [67]. However, the inhibitor of
Keap1-Cul3 complex formation affects the process of
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apoptosis by binding to Bcl-2 and its ubiquitination that
reduces the antiapoptotical potential of cells [83].
Fibroblasts are characterized by two different mechan-
isms for the inactivation of the transcription factor Nrf2.
Except for the cytoplasmic inhibitor, Keap1, fibroblasts
also have a second mechanism of binding and inactivation
of Nrf2 using a caveolae that are a vesicular structures
formed by a dent fibroblast cell membranes [117]. They are
also observed in adipocytes and endothelial cells, and their
main function is to participate in membrane trafficking and
endocytosis [100]. Therefore, it is believed that they can
also take part in the degradation of factor Nrf2, but the
exact mechanism of Nrf2-caveolae interaction has not yet
been elucidated [64]. Dual mechanism of Nrf2 binding
existing in fibroblasts probably allows cells to increase the
pool of this factor in the cytoplasm under physiological
conditions and thus to faster and stronger immune response
to oxidative stress conditions.
Fibroblasts are cells able to differentiate. Cell culture
studies suggest that inhibition of Nrf2 activity by treating
cells with TGF-b leads to an increase in the level of ROS
that can cause fibrosis and fibroblast differentiation to
miofibrocytes [121]. However, the level of endogenous
TGF-b as well as fibrosis process can be inhibited by Nrf2
activators such as SFN or trichostan that enhance Nrf2
binding to DNA [128]. The Nrf2 level/activity may also be
affected by hormonal signaling molecules including ERRa
(estrogen-related receptor a), but the mechanism of their
interaction has not been found yet [96]. One of the better-
known Nrf2 activation mechanisms used in the treatment
of skin diseases is the action of curcumin. Therefore, cur-
cumin, a turmeric root extract, has been demonstrated to
induce antifibrotic cell activity. Curcumin disturbs the
TGF-b signaling in systemic scleroderma (SSc), by coun-
teracted phosphorylation of Smad2 and induced upregula-
tion of TGF-b-induced factor (TGIF)—a negative regulator
of TGF-b signaling. Moreover, curcumin-mediated Nrf2
activation leads to a decrease in the level of ROS that can
cause suppression of fibrotic process in scleroderma [110,
122, 123].
Nrf2 activators in fibroblasts
The activity of fibroblast Nrf2 is also reduced by thiol
antioxidants such as thioredoxin that free thiol group may
prevent Keap1 oxidation, which favors the maintenance of
Nrf2 in Keap1 complex. However, during oxidative stress,
the level of antioxidants including thioredoxin is reduced,
and its effect on Nrf2 is abolished [90]. Other natural
compounds that affect the activity of Nrf2 are eotaxins.
Eotaxin-1/CCL11 is a natural chemokine, which appears in
the intracellular matrix as a response to occurrence of
stress. This chemokine increases the activity of Nrf2 in
cultured fibroblasts [22], while in skin cells, patients with
atopic skin eotaxin-1/CCL11 level are reduced which is
contributed to the reduced activity of Nrf2 and decreased
antioxidant skin cells capacity [88].
The Nrf2 activity is also involved in Mrp family ex-
pression (multidrug resistance-associated proteins) [71].
Mrp proteins are ATP-dependent membrane transporters,
and their main function is to remove, from the cell, glu-
tathione conjugates with harmful substances—mainly
metabolites of drugs [61]. The highest Mrp level is noted in
the hepatocytes, but in the skin fibroblasts, the level of
these proteins is also high [87]. Studies on fibroblasts
isolated from Nrf2 knockout mice (-/-) show that MRP1
transcript level in these cells was significantly lower
compared to the control cells. Moreover, in fibroblasts Nrf2
(?/?) treated with diethyl maleate, increase in the Mrp1
level was observed, while in the case of fibroblasts Nrf2
(-/-), there was no such reaction [29]. Those results
indicate that Nrf2 in fibroblasts has influence on both
constitutive and inducible Mrp family expression.
The fibroblasts Nrf2 activity is also modified by many
others natural compounds including polyphenols, such as
curcumin, EGCG (epigallocatechin-3-gallate) or apomor-
phine, and flavone derivatives as well as components of
pepper betle, brassica plants, and walnut sprouts extracts
[28]. Polyphenols affect Nrf2 activity by effecting sig-
naling pathways associated with p38, B-Raf, and NF-jB
[4, 77]. However, flavone derivatives enhance Nrf2 level/
activity by increase in fibroblast line NIH3T3 Nrf2
mRNA level and in active Nrf2 via activation of ERK1/2
[21, 102]. Natural Nrf2 activators are also found in the
brassica plants. One of these compounds which increases
the activity of Nrf2 and not causes toxic effects on
NIH3T3 cells is 3,3-diindolylometan which is derived
from indol-3-carbinol fermentation [20]. Walnut sprouts
extracts also contain natural Nrf2 activators that cause an
increase in cells resistance to oxidative stress and increase
survival up to 50 % in the case of fibroblast cells exposed
to UVB [13].
Uncontrolled activation of Nrf2 in skin cells
Most of the results suggest rather beneficial effects of Nrf2
activation under physiological conditions. However, Nrf2
activity is inhibited by Keap1, and deletion of this second
protein gene in mice caused death of these animals within
the first 3 weeks after birth due to hyperkeratosis in the
esophagus and stomach, resulting in nutrient obstruction
and stomach ulceration. These mice also revealed severe
scaling and hyperthickening of the cornified layer of the
epidermis [79, 119]. It was also shown that chronic Nrf2
Arch Dermatol Res (2015) 307:385–396 391
123
activation causes sebaceous gland enlargement and sebor-
rhea in mice keratinocytes due to upregulation of the
growth factor epigen, which was identified as a novel Nrf2
target [105]. It was accompanied by thickening and hy-
perkeratosis of hair follicle infundibula. These abnor-
malities caused dilatation of infundibula, hair loss, and cyst
development upon aging. Upregulation of epigen, secretory
leukocyte peptidase inhibitor (Slpi), and small proline-rich
protein 2d (Sprr2d) in hair follicles was identified as the
likely cause of infundibular acanthosis, hyperkeratosis, and
cyst formation. These alterations were highly reminiscent
to the phenotype of metabolizing acquired dioxin-induced
skin hamartomas (MADISH) patients. Indeed, Slpi, Sprr2d,
and epigen were strongly expressed in cysts of MADISH
patients and upregulated by dioxin in human keratinocytes
in an Nrf2-dependent manner. These results identify novel
Nrf2 activity in the pilosebaceous unit and a role of Nrf2 in
MADISH pathogenesis [105]. Other findings suggest that
the constitutive activation of Nrf2 in the epidermis and its
binding to the promoters of differentiation-specific genes in
keratinocytes may lead to abnormal enhancement of ker-
atinocytes [6].
Summary
The protection of proper skin functions needs cooperation
of different mechanisms. One of them protects cellular
components against oxidative damages by antioxidant
proteins biosynthesis which is dependent on transcription
factor Nrf2 activity (Fig. 1). The increase in the activity of
Nrf2 enhances cell resistance to oxidative stress caused by
UV and chemicals and in consequence could prevent ma-
lignant transformation. Nrf2, especially in keratinocytes
and melanocytes, protects these cells against mutation
during process of keratinization and melanogenesis. How-
ever, fibroblast Nrf2 plays an important role in protection
of these cells against differentiation and fibrosis. Moreover,
Nrf2 participation in wound healing and inflammation in-
hibition is also essential for maintaining the integrity of the
skin.
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